Reference priceRUB ₽348.72Original source price: INR 317.02. Converted estimates are available by currency selection.
| Brand | Emcure Pharmaceuticals Ltd |
|---|---|
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Prescription required | Yes |
Dynulta Tablet
Sucroferric oxyhydroxide (2500mg)
Description
Dynulta Tablet contains the active component sucroferric oxyhydroxide. It is classified as a phosphate binder. This medication treats hyperphosphatemia in patients with chronic kidney disease (CKD) who are on dialysis. Hyperphosphatemia is characterized by abnormally high levels of phosphate in the blood, a common complication of CKD. This medicine contains iron, which can benefit individuals with CKD who often experience iron deficiency anemia. Providing iron and phosphate binding helps address iron deficiency and support red blood cell production.Benefits
In Treatment of High phosphate levels in blood Our body needs phosphate for various life functions such as strengthening of bones and teeth, production of energy, improve the function of nerves and muscles. But too much phosphate in our blood can cause serious complications such as heart attack, stroke as well as kidney damage. Dynulta Tablet helps to lower the phosphate levels in our blood and prevents these complications particularly in patients who are on dialysis and are unable to get rid of excess phosphate levels through kidneys. Take Dynulta Tablet as prescribed by the doctor to get the most of this medicine.How to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Dynulta Discoloration of stool Diarrhea Nausea Taste changeЭта информация носит справочный характер. Перед применением лекарства проконсультируйтесь с медицинским специалистом.